Pharmaceutical Companies

cvs.jpg
April 7, 2021

Pharmacies face peril without opioid settlements, Cleveland federal judge says

CVS Health Corp., Walgreens Boots Alliance and other pharmacy chains face mounting pressure to settle thousands of government lawsuits over their role in the U.S. opioid epidemic after a federal judge warned the companies they risk financial peril.
pharmacist.jpg
January 3, 2021

Former Walmart Pharmacists Say Company Ignored Red Flags As Opioid Sales Boomed

When Ashwani Sheoran showed up for early morning shifts at pharmacies in rural Michigan wearing his white Walmart smock, he often found customers waiting, desperate for bottles of pain pills.
spectrum-news-1.jpg
December 17, 2020

How COVID-19 is Fueling the Opioid Crisis in Ohio

What You Need To Know: - Family behind Purdue Pharma testified before Congress on Thursday - Ohio lawmakers are pushing to refocus attention on worsening opioid crisis - OSU addiction specialist says pandemic “definitely” led to resurgence of opioid epidemic
law_360.png
December 7, 2020

Another Opioid Bellwether Delayed For COVID-19

Law360 (December 7, 2020, 5:32 PM EST) -- An Ohio federal judge on Friday moved the May 2021 trial date for a bellwether case brought by two Ohio counties against pharmacies in the opioid multidistrict litigation to October 2021 due to concerns over the coronavirus pandemic.
purdue_pharma.jpg
November 25, 2020

OxyContin maker Purdue Pharma pleads guilty in criminal case

Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.
cleveland_website.jpg
November 6, 2020

Ohio backs $26 billion plan to settle nationwide opioid lawsuits with major drug companies

CLEVELAND, Ohio – Four of the nation’s largest pharmaceutical companies are prepared to pay $26 billion to settle lawsuits with communities and states across the country over the devastation brought on by prescription painkillers.
jdsupra.png
November 5, 2020

Sixth Circuit Rejects Certification of Novel “Negotiation Class” in Multidistrict Opioid Litigation

On September 24, 2020, the Sixth Circuit reversed the Northern District of Ohio’s certification of a “negotiation class” in a nationwide prescription opioid MDL, concluding the text of Rule 23 does not permit certification of a class for negotiation purposes, as opposed to litigation or settlement.
the_new_york_times.png
October 21, 2020

Purdue Pharma Plea Offers Little Solace to Survivors of Opioid Crisis

The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.
Close